Pharmanutra
Develops and distributes nutritional supplements and medical devices based on research.
PHN | XMIL
Overview
Corporate Details
- ISIN(s):
- IT0005274094
- LEI:
- 815600F8217BC7733697
- Country:
- Italy
- Address:
- VIA CAMPODAVELA, 1, 56122 PISA
- Website:
- http://www.pharmanutra.it
- Sector:
- Manufacturing
Description
PharmaNutra is a company operating in the pharmaceutical and nutraceutical sectors, focused on the development and distribution of nutritional supplements and medical devices. Grounded in scientific research, the company creates innovative solutions for health and wellness. Its core activities center on addressing nutritional deficiencies, particularly iron, through proprietary functional ingredients and technologies. The product portfolio also extends to supporting muscle and joint health, sports nutrition, and applications across various therapeutic areas, including gynecology, orthopedics, hematology, and gastroenterology. The company emphasizes the development of effective and safe products supported by clinical evidence.
Unlock This Filing & Millions More
You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.
Filings
| Date | Filing | Language | Size | Actions | |
|---|---|---|---|---|---|
| 2022-03-18 20:12 |
PR - PHARMANUTRA - Draft Financial Statements 2021
|
English | 311.7 KB | ||
| 2022-03-18 18:43 |
PR - PHARMANUTRA - Shareholder's Meeting documents
|
English | 175.1 KB | ||
| 2022-03-18 18:42 |
CS - PHARMANUTRA - Documentazione Assemblea degli azionisti
|
Italian | 174.4 KB | ||
| 2022-03-18 18:39 |
PR - PHARMANUTRA - Notice of call Shareholders' Meeting
|
English | 458.2 KB | ||
| 2022-03-18 18:37 |
CS - PHARMANUTRA - Avviso di convocazione Assemblea degli Azionisti
|
Italian | 442.8 KB | ||
| 2022-03-18 18:00 |
CS Pharmanutra - Approvazione progetto di Bilancio 2021
|
Italian | 299.9 KB | ||
| 2022-03-08 18:04 |
Allegato 3F - Febbraio 2022
|
Italian | 64.2 KB | ||
| 2022-02-23 17:40 |
PR PHARMANUTRA - Modification corporate events 2022
|
English | 170.6 KB | ||
| 2022-02-23 17:39 |
CS PHARMANUTRA - Rettifica calendario eventi societari 2022
|
Italian | 170.6 KB | ||
| 2022-02-14 08:20 |
PR - PHARMANUTRA - UE authorises CFA as Novel Food
|
English | 182.2 KB | ||
| 2022-02-14 08:19 |
CS - PHARMANUTRA - UE autorizza CFA come Novel Food
|
Italian | 186.7 KB | ||
| 2022-02-07 11:02 |
Allegato 3F - Gennaio 2022
|
Italian | 62.9 KB | ||
| 2022-01-31 18:18 |
PR - PHARMANUTRA 2021 sales report 31_01_2022
|
English | 178.7 KB | ||
| 2022-01-31 18:16 |
CS - PHARMANUTRA dati vendita esercizio 2021
|
Italian | 182.5 KB | ||
| 2022-01-24 18:38 |
PR - PHARMANUTRA Initiation of share buy-back program
|
English | 180.1 KB |
Automate Your Workflow. Get a real-time feed of all Pharmanutra filings delivered via API.
Market Data
Market Data Not Available
Financials & KPIs
Unlock Full Financials for Pharmanutra
This data is available as part of our premium data solutions. Contact our team for access.
Need More History? Access decades of standardized financials for Pharmanutra via our API.
Insider Transactions
| Date | Insider Name | Position | Type | Shares | Value |
|---|---|---|---|---|---|
| No insider transactions recorded for this company. | |||||
Peer Companies
